Lucien D. D'Hinterland
9Patents
5h-index
10Co-inventors
60Inventor score
Filing activity: Dec 3, 1974 → May 22, 1995
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US4460575A | Vaccinal complex containing a specific antigen and vaccine containing it | Emerging Cross-Sectional Technologies | 52 | Expired |
| US5830994A | Peptide derivatives of alpha-MSH and their application | Human Necessities | 28 | Expired |
| US3998947A | Process for obtaining a plasminogen activator | Emerging Cross-Sectional Technologies | 25 | Expired |
| US4297272A | Process for the preparation of purified bacterial membranal proteoglycans | Emerging Cross-Sectional Technologies | 10 | Expired |
| US4397838A | Preparations of purified bacterial membranal proteoglycans | Emerging Cross-Sectional Technologies | 9 | Expired |
| US4349540A | Process for preparing vaccines based on antigenic ribosomal fractions | Human Necessities | 4 | Expired |
| US4937327A | Derivative of D.25, process for its preparation, its use as an immunostimulant, and pharmaceutical compositions containing the derivative | Human Necessities | 3 | Expired |
| US5362474A | Method for detecting and locating inflammatory or tumor foci in a patient and diagnostic kit therefor | Human Necessities | 1 | Expired |
| USRE30309E | N-Alkyl-3-pyridinium-methanol fluorides and derivatives thereof | General | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.